Published in Blood Weekly, September 13th, 2001
"Indinavir (IDV) is a potent and selective human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI) widely used in antiretroviral therapy for suppression of HIV, but its effects on the immune system are relatively unknown," explained Savita Pahwa and colleagues at New York University. "Recently, it has been reported that PIs inhibit lymphocyte apoptosis."
Although indinavir and other protease inhibitors may extend the lifespan of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.